The science behind NovoSerum
NovoSerum is a proprietary, cell-free cosmetic ingredient derived from purified human umbilical cord serum, collected from volunteer donors after a healthy birth. It is the core ingredient in Novo Derma Post-Procedure Cream, a finished topical cosmetic product.
What it is made from
Umbilical cord serum is sourced through a U.S.-based cord blood bank operating under FDA regulations, then processed to remove cellular material. It contains no stem cells and no living cells.
What remains is a concentrate of approximately 350 total molecules, including proteins, cell signalers, nutrients, peptides and vitamins, formulated into a topical cosmetic cream.
Novo Derma is not sold or marketed as a peptide product or peptide therapy. It is also not an exosome product, cellular therapy, injectable or regenerative-medicine procedure.
Category
Novo Derma is
Novo Derma is not
Where Novo Derma fits
Novo Derma Post Procedure Cream is a professional-grade topical cosmetic product designed to accompany the days that follow an aesthetic service. It gives clients a dedicated take-home step focused on hydration, comfort, skin appearance and a simple at-home routine.
NovoSerum mechanism
This diagram illustrates the procollagen and GAG mechanism examined in the studied NovoSerum formulation. It is provided as research background, not as a consumer promise or expected outcome.
Research background
In academic research conducted under double-blind conditions by Dr. Robert Lavker, Director of Dermatology Research at Northwestern University Medical School, each subject was treated on one site with the studied NovoSerum formulation and on the opposite site with vehicle only. The findings below describe that studied formulation and are provided as research background, not as a consumer promise or expected outcome.
Procollagen — studied formulation vs. vehicle only
| Subject | Change |
|---|---|
| Subject 1 | 1.1% ↑ |
| Subject 2 | 41.4% ↑ |
| Subject 3 | 47.5% ↑ |
| Subject 4 | 35.8% ↑ |
| Subject 5 | 17.7% ↑ |
| Subject 6 | 13.0% ↓ |
Reported change in 6 study subjects — average of approximately 28.7%.
GAGs — studied formulation vs. vehicle only
| Subject | Change |
|---|---|
| Subject 1 | 80.0% ↑ |
| Subject 2 | 43.0% ↑ |
| Subject 3 | 58.7% ↑ |
| Subject 4 | 16.7% ↓ |
| Subject 5 | 37.8% ↑ |
| Subject 6 | 22.3% ↑ |
Reported change in 6 study subjects — average of approximately 48.4%.
Research findings relate to the formulation studied in that academic research. Novo Derma Post-Procedure Cream is a topical cosmetic product and is not represented as providing any therapeutic or medical outcome.
Patent
NovoSerum is proprietary technology associated with U.S. Patent No. 8,790,710 B and supported by academic research. Novo Derma incorporates that technology into a finished, non-prescription topical cosmetic cream created for professional post-procedure aftercare in aesthetic practices.
U.S. Patent No. 8,790,710 B
Research foundation
NovoSerum is a patented serum technology (U.S. Patent No. 8,790,710 B) and the platform behind every Novo Derma formulation.
Umbilical cord serum from volunteer donors after a healthy birth, sourced through a U.S.-based cord blood bank operating under FDA regulations.
Double-blind research conducted by Dr. Robert Lavker, Director of Dermatology Research, Northwestern University Medical School.
Research & references